Intravitreal Bevacizumab and Low Fluence Photodynamic Therapy
NCT00802126
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Myopia
Interventions
DRUG:
Combination therapy "IVB + rf-PDT"
Sponsor
University of Campania Luigi Vanvitelli